| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/28/2007 | EP1756088A1 Quinazoline derivatives as erbb receptor tyrosine kinases |
| 02/28/2007 | EP1756084A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/28/2007 | EP1756076A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 02/28/2007 | EP1756074A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/28/2007 | EP1756072A2 Purification of progesterone receptor modulators |
| 02/28/2007 | EP1756069A2 Hiv integrase inhibitors |
| 02/28/2007 | EP1756065A1 Anti-cytokine heterocyclic compounds |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1755601A2 Inhibitors of histone deacetylase |
| 02/28/2007 | EP1755585A1 Transthyretin stabilization |
| 02/28/2007 | EP1458703B1 Isochroman compounds for treatment of cns disorders |
| 02/28/2007 | EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | EP1309592B9 Substituted pyrazoles |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | CN1922180A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 02/28/2007 | CN1922177A Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors |
| 02/28/2007 | CN1922174A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 02/28/2007 | CN1922172A Substituted heterocyclic compounds and uses thereof |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922170A Novel hydroxy-6-heroarylphenanthridines and their use as pde4 inhibitors |
| 02/28/2007 | CN1922160A Compounds |
| 02/28/2007 | CN1922151A Substituted azole derivatives, compositions, and methods of use |
| 02/28/2007 | CN1922148A Pyrazole derivatives as protein kinase modulators |
| 02/28/2007 | CN1922146A Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
| 02/28/2007 | CN1922141A Novel heterocyclic compound |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1919842A Oxdiazole derivative and application thereof in electroluminescent material |
| 02/28/2007 | CN1301994C Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 02/28/2007 | CN1301969C New mandelic acid derivatives and their use as thrombin inhibitors |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/27/2007 | US7183413 Aminoquinoline compounds |
| 02/27/2007 | US7183408 calcium atorvastatin (Lipitor) intermediate; from claimed intermediate 5-(4-fluorophenyl)-2-isopropyl-1-(3-morpholin-4-yl-3-oxo-propyl)-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide; via diol esters from the 1,3,5-tricarbonyl precursors in a stereoselective ruthenium-catalyzed hydrogenation |
| 02/27/2007 | US7183313 Keto cannabinoids with therapeutic indications |
| 02/27/2007 | US7183306 Pyrazole derivatives |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183301 Such as (5R)-3-(3-fluoro-4-(2-oxo-1,3-oxazolan-3-yl)phenyl)-5-hydroxymethyl-1,3 -oxazolan-2-one |
| 02/27/2007 | US7183296 Anti-HIV pyrazole derivatives |
| 02/27/2007 | US7183295 Compound for treatment of lipemic agents, antiinflammatory agents and treatment of diabetes |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183278 (Halo)alkoxy-3-(alkoxy or alkanoyl)-N-alkylene picolinamide; reacting a picolinic acid, ester or acyl halide with a primary amine; agricultural fungicides; rice blast, cucumber anthracnose, powdery mildew of cucumber and wheat leaf rust |
| 02/27/2007 | US7183276 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy |
| 02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
| 02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/27/2007 | US7183238 microbicides, pesticides and herbicides |
| 02/22/2007 | WO2007022257A2 Monocyclic and bicyclic compounds and methods of use |
| 02/22/2007 | WO2007021794A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | WO2007021793A1 Macrocyclic diaminopropanes as beta-secretase inhibitors |
| 02/22/2007 | WO2007021711A2 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/22/2007 | WO2007021573A1 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | WO2007021309A1 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
| 02/22/2007 | WO2007020936A1 Bicyclo heterocyclic compound having antifungal action |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020411A1 Amide derivatives |
| 02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | WO2007020190A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/22/2007 | WO2007000550A3 Novel indoline compounds |
| 02/22/2007 | WO2006134163A8 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 02/22/2007 | WO2005120516A3 Hiv integrase inhibitors |
| 02/22/2007 | US20070043223 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 02/22/2007 | US20070043093 Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 02/22/2007 | US20070043080 Substituted anilinic piperidines as MCH selective antagonists |
| 02/22/2007 | US20070043065 Amide derivatives |
| 02/22/2007 | US20070043062 Isoxazoles as peptide deformylase inhibitors |
| 02/22/2007 | US20070043061 Furazanobenzimidazoles |
| 02/22/2007 | US20070043060 Inflammations of the respiratory system, locomotor system traumas, and edemas; 1-{[5-(4-Chlorophenyl)-4-(2,4-dichlorophenyl)-1,3-oxazol-2-yl]carbonyl}-4-(3-methylphenyl)piperazine |
| 02/22/2007 | US20070043059 N-oxides as prodrugs of piperazine and piperidine derivatives |
| 02/22/2007 | US20070043056 5-Substituted-2-arylpyrazines |
| 02/22/2007 | US20070043051 Methods and compositions of novel triazine compounds |
| 02/22/2007 | US20070043048 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 02/22/2007 | US20070043045 Novel high affinity thiophene-based and furan-based kinase ligands |
| 02/22/2007 | US20070043043 Benzimidazole derivates: preparation and pharmaceutical applications |
| 02/22/2007 | US20070043042 Quinoline potassium channel inhibitors |
| 02/22/2007 | US20070043041 Indol-6 sulfonamide derivative, their preparation and their use 5-ht-6 as modulators |
| 02/22/2007 | US20070043040 Inhibitors of akt (protein kinase b) |
| 02/22/2007 | US20070043038 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 02/22/2007 | US20070043037 Pyrimidine derivatives as orexin receptor antagonists |
| 02/22/2007 | US20070043036 2-Pyridone derivatives as neutrophil elastase inhibitors and their use |
| 02/22/2007 | US20070043020 Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| 02/22/2007 | US20070043016 Method of treating fibrotic diseases or other indications with imidazolium agents |
| 02/22/2007 | US20070043015 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 02/22/2007 | US20070043014 3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists |
| 02/22/2007 | US20070043013 1,3 Disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 02/22/2007 | US20070043010 Quinazoline derivatives |
| 02/22/2007 | US20070043001 Cancer; 1-(1-{4-[5-(5-amino-1,3,4-thiadiazol-2-yl)-3-phenylpyridin-2-yl]benzyl}piperidin-4-yl) -1H-pyrazolo[3,4-d]pyrimidin-4-amine; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, enhanced pharmacokinetic properties |
| 02/22/2007 | CA2619706A1 Novel high affinity quinoline-based kinase ligands |
| 02/22/2007 | CA2619407A1 Bicyclic bisamide derivatives and use thereof as insecticides |
| 02/22/2007 | CA2619223A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/22/2007 | CA2619010A1 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/22/2007 | CA2618747A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2618451A1 Amide derivatives |
| 02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | CA2616307A1 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1754701A1 Sulfonyloxy derivatives |